Kristina Feldberg

Nintedanib Targets KIT D816V Neoplastic Cells Derived from Induced Pluripotent Stem cells of Systemic Mastocytosis

S. Mustjoki, T. Brümmendorf, J. Panse, 2020, bioRxiv.

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation

T. Brümmendorf, G. Müller-Newen, I. Costa, 2018, Leukemia.

The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients

S. Mustjoki, T. Brümmendorf, S. Koschmieder, 2017, Oncotarget.

Differential roles of STAT1 and STAT2 in the sensitivity of JAK2V617F- vs. BCR-ABL-positive cells to interferon alpha

T. Brümmendorf, Manuel Allhoff, I. Costa, 2019, Journal of Hematology & Oncology.

Macrophage HIF‐2α regulates tumor‐suppressive Spint1 in the tumor microenvironment

T. Brümmendorf, A. Reiter, S. Koschmieder, 2019, Molecular carcinogenesis.

Molecular Carcinogenesis

T. Brümmendorf, M. Schemionek, N. Chatain, 2019 .

STAT1 Transcriptional Response Predicts Molecular Responses of PB-Derived Clonogenic Cells from MPN Patients to Interferon Alpha

T. Brümmendorf, S. Koschmieder, N. Chatain, 2019, Blood.

Molecular Carcinogenesis

M. Schemionek, M. Jawhar, D. Gezer, 2019 .